We are live on ! Find out more
CJL

Cyrus J. Lawrence Portfolio holdings

AUM $26.4M
1-Year Est. Return 16.63%
This Fund
S&P 500
This Quarter Est. Return
+7.37%
1 Year Est. Return
+16.63%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$494M
AUM Growth
+$42.7M
Cap. Flow
+$6.06M
Cap. Flow %
1.23%
Top 10 Hldgs %
43.7%
Holding
176
New
26
Increased
32
Reduced
32
Closed
5
Avg Time Held
6.1 quarters
Top 10 Avg Time Held
4.2 quarters
Top 20 Avg Time Held
3.9 quarters

Top Buys

Rank Stock Value
1
PH icon
Parker-Hannifin
PH
+$7.68M
2
UBER icon
Uber
UBER
+$7.63M
3
GEHC icon
GE HealthCare
GEHC
+$6.75M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$5.54M
5
FISV icon
Fiserv Inc
FISV
+$4.7M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$7.48M
2
ROK icon
Rockwell Automation
ROK
+$6.92M
3
SLB icon
SLB Ltd
SLB
+$6.42M
4
CVS icon
CVS Health
CVS
+$6.06M
5
SBUX icon
Starbucks
SBUX
+$2.69M

Sector Composition

Rank Sector Weight
1 Technology 39.93%
2 Healthcare 14.36%
3 Financials 12.45%
4 Communication Services 11%
5 Consumer Discretionary 8.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
MSFT icon
1
Microsoft
MSFT
$4.04T
$39.3M 7.97%
87,785
+130
+0.1% +$54.9K
2022 Q1
9 quarters
NVDA icon
2
NVIDIA
NVDA
$5.52T
$29.4M 5.96%
238,228
+5,038
+2% +$509K
2022 Q1
9 quarters
AAPL icon
3
Apple
AAPL
$4.98T
$22.2M 4.5%
105,392
-106
-0.1% -$19.8K
2022 Q1
9 quarters
META icon
4
Meta Platforms (Facebook)
META
$1.94T
$21.5M 4.36%
42,667
+9,417
+28% +$4.58M
2022 Q1
9 quarters
LLY icon
5
Eli Lilly
LLY
$1.04T
$19.2M 3.9%
21,251
-25
-0.1% -$20K
2022 Q1
9 quarters
AMZN icon
6
Amazon
AMZN
$2.79T
$18.9M 3.83%
97,804
+1,195
+1% +$220K
2022 Q1
9 quarters
GOOGL icon
7
Alphabet (Google) Class A
GOOGL
$4.33T
$17.7M 3.59%
97,387
-47
-0% -$7.92K
2022 Q1
9 quarters
PANW icon
8
Palo Alto Networks
PANW
$325B
$16.4M 3.32%
96,566
-90
-0.1% -$13.5K
2022 Q1
9 quarters
COST icon
9
Costco
COST
$423B
$15.7M 3.19%
18,509
+281
+2% +$219K
2022 Q1
9 quarters
AVGO icon
10
Broadcom
AVGO
$1.71T
$15.2M 3.08%
94,790
-60
-0.1% -$8.41K
2023 Q2
4 quarters
BX icon
11
Blackstone
BX
$82.6B
$12.6M 2.54%
101,426
+53
+0.1% +$6.52K
2022 Q1
9 quarters
FISV icon
12
Fiserv Inc
FISV
$24.8B
$12.5M 2.54%
83,947
+31,038
+59% +$4.7M
2023 Q1
5 quarters
VRTX icon
13
Vertex Pharmaceuticals
VRTX
$123B
$12.4M 2.52%
26,488
+12,769
+93% +$5.54M
2024 Q1
1 quarter
ADBE icon
14
Adobe
ADBE
$92B
$12M 2.44%
21,649
-1,120
-5% -$542K
2022 Q1
9 quarters
TMUS icon
15
T-Mobile US
TMUS
$165B
$11.6M 2.34%
65,629
+243
+0.4% +$40.8K
2022 Q3
7 quarters
JPM icon
16
JPMorgan Chase
JPM
$881B
$11.5M 2.34%
57,023
-234
-0.4% -$45.7K
2022 Q1
9 quarters
J icon
17
Jacobs Solutions
J
$16.6B
$11.1M 2.24%
9,564
– –
2022 Q1
9 quarters
MA icon
18
Mastercard
MA
$530B
$10.5M 2.13%
23,823
+23
+0.1% +$10.5K
2022 Q1
9 quarters
SPGI icon
19
S&P Global
SPGI
$121B
$9.59M 1.94%
21,501
+167
+0.8% +$71.6K
2022 Q1
9 quarters
HD icon
20
Home Depot
HD
$293B
$9.26M 1.88%
26,911
-1
-0% -$341
2022 Q1
9 quarters
NVO icon
21
Novo Nordisk
NVO
$168B
$9.14M 1.85%
64,018
+687
+1% +$91K
2023 Q3
3 quarters
INTU icon
22
Intuit
INTU
$80.6B
$9M 1.82%
13,699
+33
+0.2% +$20.5K
2022 Q3
7 quarters
MSI icon
23
Motorola Solutions
MSI
$74.3B
$9M 1.82%
23,305
+182
+0.8% +$65.7K
2024 Q1
1 quarter
BR icon
24
Broadridge
BR
$19B
$8.95M 1.81%
45,433
+83
+0.2% +$16.5K
2022 Q1
9 quarters
LIN icon
25
Linde
LIN
$227B
$8.64M 1.75%
19,693
-28
-0.1% -$12.3K
2022 Q1
9 quarters

Similar funds

Cyrus J. Lawrence's Q2 2024 Portfolio in Review

As of Q2 2024, Cyrus J. Lawrence held 176 positions worth $494M, up 9.5% from $451M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Cyrus J. Lawrence's Q2 2024 filing shows 26 new, 32 increased, 32 reduced and 5 closed positions. Its largest new stake was Parker-Hannifin: 14,321 shares worth $7.24M. The largest sale was UnitedHealth, an estimated $7.48M.

By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 36% a quarter earlier, followed by Healthcare and Financials.

  • Cyrus J. Lawrence's largest Q2 2024 buy was Parker-Hannifin: 14,321 shares worth $7.24M.
  • Cyrus J. Lawrence added most to Vertex Pharmaceuticals in Q2 2024, an estimated $5.54M increase.
  • Cyrus J. Lawrence's biggest Q2 2024 reduction was UnitedHealth, cutting an estimated $7.48M.
  • Cyrus J. Lawrence fully exited Mondelez International in Q2 2024, selling an estimated $70K.
  • Cyrus J. Lawrence's ten largest holdings make up 44% of its $494M portfolio in Q2 2024.
  • Cyrus J. Lawrence opened 26 new positions and closed 5 in Q2 2024.
  • Cyrus J. Lawrence's portfolio value rose 9.5% quarter-over-quarter to $494M.

Based on Cyrus J. Lawrence's 13F filing for Q2 2024, filed 13 Aug 2024.